Allergy Therapeutics, a specialty pharmaceuticals company focused on allergy vaccines, is pleased to announce that last night it was awarded the prestigious German award for pharmaceutical innovation: the MMW-Arzneimittelpreis. The award was received for Pollinex® Quattro, Allergy Therapeutics’ ultra short-course allergy vaccine product containing the innovative adjuvant MPL®, and was presented at a ceremony in Aachen.
